ENLIE Pharmaceutical JSC (HSTC:BCP) Buyback Yield %: 0.00 (As of Jul. 05, 2026)


HSTC:BCP ENLIE Pharmaceutical JSC HSTC:BCP
25 GF Score
Price ₫10,600.00
View Full Analysis

What is ENLIE Pharmaceutical JSC Buyback Yield %?

ENLIE Pharmaceutical JSC HSTC:BCP 25 Buyback Yield % is 0.00 as of Jul. 05, 2026. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100. Among 292 Drug Manufacturers companies, ENLIE Pharmaceutical JSC ranks worse than 342465.41% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

ENLIE Pharmaceutical JSC's current buyback yield was 0.00%.

ENLIE Pharmaceutical JSC Buyback Yield % Related Terms

ENLIE Pharmaceutical JSC Buyback Yield % Historical Data

* Premium members only.

The historical data trend for ENLIE Pharmaceutical JSC's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENLIE Pharmaceutical JSC Buyback Yield % Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
Buyback Yield %

ENLIE Pharmaceutical JSC Semi-Annual Data
Buyback Yield %

HSTC:BCP vs : Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENLIE Pharmaceutical JSC Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's Buyback Yield % falls into.


HSTC:BCP
25GF Score
ENLIE Pharmaceutical JSC HSTC:BCP
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENLIE Pharmaceutical JSC Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

ENLIE Pharmaceutical JSC's Buyback Yield for the fiscal year that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- ( + ) /
=N/A%

ENLIE Pharmaceutical JSC's annualized Buyback Yield for the quarter that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- ( + ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Buyback Yield % of 0.00 as of Jul. 05, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on ENLIE Pharmaceutical JSC and its competitors. According to the industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 292 companies in the Drug Manufacturers industry.
Is ENLIE Pharmaceutical JSC's Buyback Yield % too high?
ENLIE Pharmaceutical JSC's current Buyback Yield % is 0.00. Based on the distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 292 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Buyback Yield % compare to ?
According to the Drug Manufacturers industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 292 companies for Buyback Yield %. This places ENLIE Pharmaceutical JSC in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on ENLIE Pharmaceutical JSC and its competitors. ENLIE Pharmaceutical JSC's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Buyback Yield % is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENLIE Pharmaceutical JSC Business Description

Comparable Companies
Address NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score

Get the complete analysis for HSTC:BCP

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫10,600.00
Price